Início › Câncer de Pulmão › Califórnia

Ensaios clínicos de Câncer de Pulmão em Califórnia

112 estudos para Câncer de Pulmão estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Kaiser Permanente-Anaheim, Anaheim
Kaiser Permanente-Deer Valley Medical Center, Antioch
Sutter Auburn Faith Hospital, Auburn
e mais 56

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848

Smoking Cessation CM for Veterans With or at Risk for Cancer

San Francisco VA Medical Center, San Francisco, CA, San Francisco

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06432985

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
e mais 10

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
e mais 20

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Kaiser Permanente-Deer Valley Medical Center, Antioch
Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
e mais 23

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT04181060

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06625775

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Tower Cancer Research Foundation, Beverly Hills
Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
e mais 20

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Hoag Hospital Newport Beach, Newport Beach
University of California, Irvine Health, Orange

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

MemorialCare Long Beach Medical Center, Long Beach

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Los Angeles
PHN-012-001 Site, San Diego

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

City of Hope National Medical Center, Duarte
UC San Diego Medical Center - Encinitas, Encinitas
City of Hope Lennar Foundation Cancer Center, Irvine
e mais 9

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07476287

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

GSK Investigational Site, Los Angeles

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07099898

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Beverly Hills Cancer Center ( Site 0070), Beverly Hills
UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles
Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Oncura Health - Anaheim, Anaheim
Memorial Care Orange Coast Medical Center Attn, Fountain Valley
MemorialCare Orange Coast Medical Center, Fountain Valley
e mais 20

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Sansum Clinic, Santa Barbara

RecrutandoFase 3

Idades de 18 a 100 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05920356

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Stanford Cancer Institute, Stanford
Stanford Hospital and Clinics, Stanford
Stanford Hospital Investigational Drug Services, Stanford

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07489066

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
Providence St. Jude Medical Center, Fullerton
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06758401

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

The City of Hope Orange County Lennar Foundation Cancer Center, Irvine

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07154290

A Registry for People With Lung Cancer

University of California San Diego (Data collection), San Diego

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06424327

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0497, Los Alamitos
USC/Norris Comprehensive Cancer Center, Los Angeles

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07063745

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

GSK Investigational Site, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07602855

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Los Angeles

RecrutandoFase 2

Idades de 18 a 95 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05061550

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

John Muir Clinical Research Center, Concord
University Of California - San Diego Moores Cancer Center, La Jolla

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care building, Irvine
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07100080

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

UCI Health Family Health Center - Anaheim, Anaheim
UCI Health - Costa Mesa, Costa Mesa
CHAO Family Comprehensive Cancer Center- Irvine, Irvine
e mais 10

Recrutando

Idades de 50 a 80 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07711691

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

City of Hope Comprehensive Cancer Center, Duarte
City of Hope at Irvine Lennar, Irvine
UC San Diego Moores Cancer Center, La Jolla
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06287775

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Los Alamitos Hematology/Oncology Medical Group, Glendale
MemorialCare Todd Cancer Institute, Long Beach
Valkyrie Clinical Trials, Los Angeles

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07625644

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles
University of California, San Francisco (UCSF), San Francisco

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT05786924

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Community Cancer Institute (CCI), Clovis
Marin Cancer Care Inc, Greenbrae
UCI Health-CIACC, Irvine
e mais 6

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Cedars-Sinai Medical Center, Los Angeles
BASS Cancer Center, Walnut Creek

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

UCLA, Santa Monica

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06561685

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

University of California Davis Comprehensive Cancer Center, Sacramento

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07012031

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06400472

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Los Angeles
Avenzo Therapeutics Recruiting Site, Los Angeles

RecrutandoFase 1/2

Idades de 18 a 75 · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

University of California - San Diego Moores Cancer Center, La Jolla
University of California San Francisco, San Francisco
UCLA Health - Santa Monica Cancer Care, Santa Monica

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06343402

The Vanguard Study: Testing a New Way to Screen for Cancer

Kaiser Permanente-Division of Research, Pleasanton

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06995898

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.